Healthcare provider profile · identity verified

Anthony Michael D Agostino, MD

Internal Medicine · NAPLES, FL · NPI 1679644595

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Azithromycin	Azithromycin	310	205
Metoprolol Succinate	Metoprolol Succinate	308	86
Prednisone	Prednisone	304	188
Atorvastatin Calcium	Atorvastatin Calcium	299	87
Amlodipine Besylate	Amlodipine Besylate	235	67
Levothyroxine Sodium	Levothyroxine Sodium	216	64
Metformin Hcl	Metformin Hcl	165	45
Rosuvastatin Calcium	Rosuvastatin Calcium	161	51
Alprazolam	Alprazolam	143	54
Losartan Potassium	Losartan Potassium	138	40
Simvastatin	Simvastatin	137	41
Omeprazole	Omeprazole	132	36
Eliquis	Apixaban	126	34
Tamsulosin Hcl	Tamsulosin Hcl	124	37
Zolpidem Tartrate	Zolpidem Tartrate	117	45
Lisinopril	Lisinopril	114	32
Hydrochlorothiazide	Hydrochlorothiazide	108	32
Pantoprazole Sodium	Pantoprazole Sodium	102	32
Sertraline Hcl	Sertraline Hcl	101	26
Methylprednisolone	Methylprednisolone	97	56
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	95	54
Synthroid	Levothyroxine Sodium	90	21
Atenolol	Atenolol	87	21
Furosemide	Furosemide	86	31
Allopurinol	Allopurinol	84	26
Trazodone Hcl	Trazodone Hcl	84	23
Gabapentin	Gabapentin	79	32
Ciprofloxacin Hcl	Ciprofloxacin Hcl	71	49
Montelukast Sodium	Montelukast Sodium	67	19
Cefdinir	Cefdinir	64	44
Ezetimibe	Ezetimibe	63	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	59	14
Potassium Chloride	Potassium Chloride	58	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	17
Metoprolol Tartrate	Metoprolol Tartrate	56	17
Enalapril Maleate	Enalapril Maleate	51	16
Escitalopram Oxalate	Escitalopram Oxalate	51	14
Bumetanide	Bumetanide	49	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	49	15
Valacyclovir	Valacyclovir Hcl	48	23
Carvedilol	Carvedilol	46	12
Glimepiride	Glimepiride	45	11
Tramadol Hcl	Tramadol Hcl	45	16
Ramipril	Ramipril	44	14
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Breo Ellipta	Fluticasone/Vilanterol	42	suppressed
Ozempic	Semaglutide	42	suppressed
Valsartan	Valsartan	41	14
Testosterone Cypionate	Testosterone Cypionate	39	14
Xarelto	Rivaroxaban	39	13
Clopidogrel	Clopidogrel Bisulfate	37	14
Jardiance	Empagliflozin	37	11
Estradiol	Estradiol	36	12
Famotidine	Famotidine	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	13
Lorazepam	Lorazepam	29	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	28	suppressed
Mupirocin	Mupirocin	28	18
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Fluconazole	Fluconazole	27	suppressed
Nitroglycerin	Nitroglycerin	27	suppressed
Mounjaro	Tirzepatide	26	suppressed
Finasteride	Finasteride	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Liothyronine Sodium	Liothyronine Sodium	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	15
Albuterol Sulfate Hfa	Albuterol Sulfate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Risperidone	Risperidone	20	suppressed
Torsemide	Torsemide	20	suppressed
Clarithromycin	Clarithromycin	19	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Tadalafil	Tadalafil	19	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	12
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	12
Clonazepam	Clonazepam	15	suppressed
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Evista	Raloxifene Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Ofloxacin	Ofloxacin	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Cromolyn Sodium	Cromolyn Sodium	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error